Global life sciences investment platform appoints VP Head of AI & Data Intelligence

September 23, 2022

Nan Fung Life Sciences (NFLS), part of the Nan Fung Group, is a $2bn global investment platform focusing on life sciences. Through direct investments via Pivotal bioVenture Partners funds and fund investments covering full spectrum of the industry (including therapeutics, medical devices, diagnostics & research tools, and Healthcare IT & Services) and across different development…

Read More

Strong SAB addition to Variant Bio secured two additional searches for LifeSci

August 19, 2022

Variant Bio is a private biotech company that offers a genomic platform for drug development companies to further their research and discover therapeutic methods that can improve patients’ lifespan. LifeSci Search partnered with Variant Bio as they sought to bring aboard a few new team members from multifaceted backgrounds to maintain their growing network of…

Read More

SVP, Head of Translational Medicine needed at Clinical Stage neurodegenerative and age-related disease focused BioPharma

July 25, 2022

Alkahest is a clinical stage biopharmaceutical company dedicated to discovering and developing treatments for neurodegenerative and age-related diseases with transformative therapies targeting the aging plasma proteome. They were acquired by Grifols, a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions in early 2021 and continues to operate…

Read More

Innovative digital molecular analysis Med Tech appoints CPDO and VP Engineering duo

March 25, 2022

Atonarp’s optical, mass spectrometer, and advanced informatic/software offerings provide the ability to “digitize” diagnostic testing. By eliminating the need for existing reagents and chemistries their technology allows for a quick diagnostic for a variety of acute and chronic diseases, amongst other standard diagnostic panels. Led by seasoned investors and raised over $100MM to date, their…

Read More